Laura E. Müller, MSc; André Schulz, PhD; Martin Andermann, Dipl-Psych; et al.
free access
JAMA Psychiatry. 2015;72(11):1077-1086. doi:10.1001/jamapsychiatry.2015.1252
This study determines the neural correlates of disturbed body awareness in borderline personality disorder and its associations with emotional dysregulation.
-
Editorial
The Heart, the Brain, and the Regulation of Emotion
Sarah N. Garfinkel, PhD; Jessica A. Eccles, MBChB, MRCPsych; Hugo D. Critchley, MBChB, DPhil, FRCPsych, FRSB
JAMA Psychiatry
Marta Peciña, MD, PhD; Amy S. B. Bohnert, PhD; Magdalena Sikora, BS; et al.
free access
JAMA Psychiatry. 2015;72(11):1087-1094. doi:10.1001/jamapsychiatry.2015.1335
This placebo trial examines the neurochemical mechanisms underlying the formation of placebo effects in patients with major depressive disorder.
Anette Riisgaard Ribe, MD; Thomas Munk Laursen, PhD; Morten Charles, MD, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1095-1101. doi:10.1001/jamapsychiatry.2015.1546
This 18-year cohort study of more than 2.8 million individuals in Denmark reports that the risk of dementia was more than 2-fold higher among those with schizophrenia, especially those younger than 65 years, compared with those without schizophrenia.
-
Editorial
Dementia in Patients With Schizophrenia: Evidence for Heterogeneity
Constantine G. Lyketsos, MD, MHS; Matthew E. Peters, MD
JAMA Psychiatry
Meta-analysis
Erica S. Weitz, MA; Steven D. Hollon, PhD; Jos Twisk, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1102-1109. doi:10.1001/jamapsychiatry.2015.1516
This meta-analysis examines baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy and antidepressant medication.
David A. Brent, MD; Steven M. Brunwasser, PhD; Steven D. Hollon, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1110-1118. doi:10.1001/jamapsychiatry.2015.1559
This randomized clinical trial determines whether a cognitive-behavioral prevention program can reduce the incidence of depressive episodes, increase depression-free days, and improve developmental competence 6 years after implementation among at-risk adolescents.
Karen E. Lythe, PhD; Jorge Moll, MD, PhD; Jennifer A. Gethin, MRes; et al.
free access
JAMA Psychiatry. 2015;72(11):1119-1126. doi:10.1001/jamapsychiatry.2015.1813
Among 75 medication-free patients with remitted major depressive disorder and no relevant comorbidity, this prospective cohort study tests the hypothesis that RSATL-SCSR connectivity for self-blaming relative to other-blaming emotions predicts subsequent recurrence of depressive episodes.
Kathryn Magruder, PhD, MPH; Tracey Serpi, PhD; Rachel Kimerling, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1127-1134. doi:10.1001/jamapsychiatry.2015.1786
This survey of 3 cohorts of women veterans from the Vietnam era assesses whether lifetime and current prevalence of posttraumatic stress disorder vary by location of service, with adjustment for demographics, military service, and wartime exposures.
David D. Vachon, PhD; Robert F. Krueger, PhD; Fred A. Rogosch, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1135-1142. doi:10.1001/jamapsychiatry.2015.1792
This observational study demonstrates that, contrary to widely held beliefs, different forms of child abuse have equivalent psychiatric effects and such abuse has similar consequences for boys and girls of different races.
Lucas Godoy Garraza, MA; Christine Walrath, PhD; David B. Goldston, PhD; et al.
free access
JAMA Psychiatry. 2015;72(11):1143-1149. doi:10.1001/jamapsychiatry.2015.1933
This observational study reports an association between implementation of the Garrett Lee Smith Memorial Suicide Prevention Program and a reduced rate of suicide attempts among youths 16 to 23 years of age, but no such effect among those older than 23 years.